US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 8.850
  • 0.0000.00%
Close Dec 3 16:00 ET
  • 8.920
  • +0.070+0.79%
Pre 09:28 ET
1.27BMarket Cap-59000P/E (TTM)

Aurinia Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aurinia Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
57.69M
67.77M
+10.08M
Beat Est.
+5.83%
+24.32%
+17.47%
EPS
0.02
0.10
+0.09
Beat Est.
+116.69%
+211.11%
+566.67%
Analyst Rating
Strong Buy

Dec 4, 2024

Aurinia Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 64.367M--
--2024/Q4-- / 59.945M--
Nov 7, 20242024/Q367.771M / 57.693M--
Aug 1, 20242024/Q257.192M / 54.690M--
May 2, 20242024/Q150.303M / 47.074M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 64.367M--
--2024/Q4-- / 59.945M--
Nov 7, 20242024/Q367.771M / 57.693M--
Aug 1, 20242024/Q257.192M / 54.690M--
May 2, 20242024/Q150.303M / 47.074M--

Unlock Free Earnings Estimates

Aurinia Pharmaceuticals Earnings Reports

  • Aurinia Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 06:23 ET

  • Aurinia Pharmaceuticals | 8-K: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS ® Growth and AUR200 Development

    Nov 7 06:18 ET

  • Aurinia Pharmaceuticals | 8-K: AURINIA PHARMACEUTICALS REPORTS SECOND QUARTER AND SIX MONTHS 2024 FINANCIAL AND OPERATIONAL RESULTS

    Aug 1 06:13 ET

  • Aurinia Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 06:12 ET

    • Read more

    Trending US Stocks
    U.S Tech Companies U.S Tech Companies
    Symbol Mini Chart % Chg
    Meta Platforms
    META
    0.00%
    Taiwan Semiconductor
    TSM
    0.00%
    Amazon
    AMZN
    0.00%
    Apple
    AAPL
    0.00%
    NVIDIA
    NVDA
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 4, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data